U.S. Guidelines Aim to Spark Genetic Drug Research (Reuters


Reuters - Hoping to spur a movement toward
"personalized medicine," U.S. regulators issued guidelines on
Tuesday that urge companies to submit data on how genetic
differences affect the way people respond to drugs.

Read more...